P. Erceg, Health-related quality of life in elderly patients hospitalized with chronic heart failure, Clin. Interv. Aging, vol.8, pp.1539-1546, 2013.

L. Liao, L. A. Allen, and D. J. Whellan, Economic burden of heart failure in the elderly, PharmacoEconomics, vol.26, pp.447-462, 2008.

T. Lane, Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis, Circulation, vol.140, pp.16-26, 2019.

F. Chiti and C. M. Dobson, Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade, Annu. Rev. Biochem, vol.86, pp.27-68, 2017.

M. Brehme, A Chaperome Subnetwork Safeguards Proteostasis in Aging and Neurodegenerative Disease, Cell Rep, vol.9, pp.1135-1150, 2014.

A. Rostagno, pH-dependent fibrillogenesis of a V?III Bence Jones protein, Br. J. Haematol, vol.107, pp.835-843, 1999.

F. Ferrone, 17] Analysis of protein aggregation kinetics, Methods in Enzymology, vol.309, pp.256-274, 1999.

K. Lundmark, Transmissibility of systemic amyloidosis by a prion-like mechanism, Proc. Natl. Acad. Sci, vol.99, pp.6979-6984, 2002.

N. Reixach, S. Deechongkit, X. Jiang, J. W. Kelly, and J. N. Buxbaum, Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture, Proc. Natl. Acad. Sci, vol.101, pp.2817-2822, 2004.

M. G. Iadanza, M. P. Jackson, E. W. Hewitt, N. A. Ranson, and S. E. Radford, A new era for understanding amyloid structures and disease, Nat. Rev. Mol. Cell Biol, vol.19, p.755, 2018.

Q. Guo, Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment, vol.172, pp.696-705, 2018.

A. Salminen, Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome, Prog. Neurobiol, pp.33-54, 2013.

K. F. Winklhofer and C. Haass, Mitochondrial dysfunction in Parkinson's disease, Biochim. Biophys. Acta, vol.1802, pp.29-44, 2010.

B. Uttara, A. V. Singh, P. Zamboni, and R. T. Mahajan, Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options, Curr. Neuropharmacol, vol.7, pp.65-74, 2009.

H. Olzscha, Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions, Cell, vol.144, pp.67-78, 2011.

S. C. Goodchild, ?2-Microglobulin Amyloid Fibril-Induced Membrane Disruption Is Enhanced by Endosomal Lipids and Acidic pH, PLOS ONE, vol.9, p.104492, 2014.

E. González-lópez, Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths, Eur. Heart J, vol.38, pp.1895-1904, 2017.

M. Orini, Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities, J. Am. Heart Assoc, 2019.

C. R. Barbhaiya, Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy, Heart Rhythm, vol.13, pp.383-390, 2016.

A. M. Jong, Atrial Remodeling Is Directly Related to End-Diastolic Left Ventricular Pressure in a Mouse Model of Ventricular Pressure Overload, PLOS ONE, vol.8, p.72651, 2013.

N. Stanley, B. Brett-&-dobrev, and . Dobromir, Atrial Remodeling and Atrial Fibrillation, Circ. Arrhythm. Electrophysiol, vol.1, pp.62-73, 2008.

. Van-den and M. P. Berg, Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis, Eur. Heart J, 2019.

L. H. Connors, Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type TransthyretinCLINICAL PERSPECTIVE: A Prospective, Observational Cohort Study. Circulation, vol.133, pp.282-290, 2016.

J. N. Buxbaum, Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?, FASEB J, vol.26, pp.2283-2293, 2012.

J. H. Pinney, Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome, J. Am. Heart Assoc, vol.2, p.98, 2013.

M. Vasala, K. Immonen, H. Kautiainen, and M. Hakala, More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases, Scand. J. Rheumatol, vol.39, pp.461-465, 2010.

S. Duhamel, Incidence and Prevalence of Light Chain Amyloidosis: A Population-Based Study, Blood, vol.130, pp.5577-5577, 2017.

M. Lee, S. Lee, Y. Kim, D. Sohn, and . Incidence, Diagnosis and Prognosis of Cardiac Amyloidosis, Korean Circ. J, vol.43, pp.752-760, 2013.

B. Ng, L. H. Connors, R. Davidoff, M. Skinner, and R. H. Falk, Senile Systemic Amyloidosis Presenting With Heart Failure: A Comparison With Light Chain-Associated Amyloidosis, Arch. Intern. Med, vol.165, pp.1425-1429, 2005.

T. P. Quock, T. Yan, E. Chang, S. Guthrie, and M. S. Broder, Epidemiology of AL amyloidosis: a real-world study using US claims data, Blood Adv, vol.2, pp.1046-1053, 2018.

E. Muchtar, Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death, Blood, vol.129, pp.2111-2119, 2017.

M. J. Semigran and . Transthyretin, Amyloidosis: A "Zebra" of Many Stripes, J. Am. Coll. Cardiol, vol.68, pp.173-175, 2016.

M. S. Maurer, Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy, N. Engl. J. Med, 2018.

C. C. Quarta, Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis, Eur. Heart J, vol.38, pp.1905-1908, 2017.

J. D. Gillmore, Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis, Circulation, vol.133, pp.2404-2412, 2016.

E. González-lópez, Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction, Eur. Heart J, vol.36, pp.2585-2594, 2015.

A. Castaño, Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement, Eur. Heart J, vol.38, pp.2879-2887, 2017.

L. Mohamed-salem, Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population, Int. J. Cardiol, 2018.

E. D. Pagourelias, O. Mirea, J. Duchenne, J. Van-cleemput, M. Delforge et al., Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis, Circulation: Cardiovascular Imaging, vol.10, issue.3, 2017.

A. Martinez-naharro, T. A. Treibel, A. Abdel-gadir, H. Bulluck, G. Zumbo et al., Magnetic Resonance in Transthyretin Cardiac Amyloidosis, Journal of the American College of Cardiology, vol.70, issue.4, pp.466-477, 2017.

R. Janani, Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association, Circulation, vol.139, pp.840-878, 2019.

A. V. Kristen, R. Bauer, F. A. Dem-siepen, S. Hein, M. Aurich et al., RISK STRATIFICATION IN WILD-TYPE TRANSTHYRETIN AMYLOIDOSIS, Journal of the American College of Cardiology, vol.67, issue.13, p.1543, 2016.

M. Grogan, C. G. Scott, R. A. Kyle, S. R. Zeldenrust, M. A. Gertz et al., Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System, Journal of the American College of Cardiology, vol.68, issue.10, pp.1014-1020, 2016.

J. D. Gillmore, T. Damy, M. Fontana, M. Hutchinson, H. J. Lachmann et al., A new staging system for cardiac transthyretin amyloidosis, European Heart Journal, vol.39, issue.30, pp.2799-2806, 2017.

E. Bishop, E. E. Brown, J. Fajardo, L. A. Barouch, D. P. Judge et al., Seven factors predict a delayed diagnosis of cardiac amyloidosis, Amyloid, vol.25, issue.3, pp.174-179, 2018.

A. Castaño, B. M. Drachman, D. Judge, and M. S. Maurer, Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs, Heart Failure Reviews, vol.20, issue.2, pp.163-178, 2014.

D. B. Richards, L. M. Cookson, A. C. Berges, S. V. Barton, T. Lane et al., Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component, New England Journal of Medicine, vol.373, issue.12, pp.1106-1114, 2015.

M. Nakagawa, Y. Sekijima, M. Yazaki, K. Tojo, T. Yoshinaga et al., Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis, Amyloid, vol.23, issue.1, pp.58-63, 2016.

E. L. Fosbøl, R. Rørth, B. P. Leicht, M. Schou, M. S. Maurer et al., Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes, Journal of the American College of Cardiology, vol.74, issue.1, pp.15-23, 2019.

B. W. Sperry, Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release, J. Am. Coll. Cardiol, vol.72, pp.2040-2050, 2018.

P. Ponikowski, ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureThe Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur. Heart J, vol.37, pp.2129-2200, 2016.

E. Perugini, Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99mTc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy, J. Am. Coll. Cardiol, vol.46, pp.1076-1084, 2005.

S. Bokhari, 99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses, Circ. Cardiovasc. Imaging, vol.6, pp.195-201, 2013.

F. O. Bastian, Amyloidosis and the Carpal Tunnel Syndrome, Am. J. Clin. Pathol, vol.61, pp.711-717, 1974.

T. Sueyoshi, Wild-type transthyretin-derived amyloidosis in various ligaments and tendons, Hum. Pathol, vol.42, pp.1259-1264, 2011.

K. Nakamichi and S. Tachibana, Amyloid deposition in the synovium and ligament in idiopathic carpal tunnel syndrome, Muscle Nerve, vol.19, pp.1349-1351, 1996.

Y. Sekijima, High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly, Hum. Pathol, vol.42, pp.1785-1791, 2011.

N. Fouquet, F. Sillam, C. Ha, G. Raimbeau, and Y. Roquelaure, Part de l'activité professionnelle dans la survenue du syndrome du canal carpien dans deux départements français, Rev. DÉpidémiologie Santé Publique, vol.62, p.188, 2014.

A. A. Satoskar, Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing, Am. J. Surg. Pathol, vol.35, pp.1685-1690, 2011.

D. M. Yamaguchi, P. R. Lipscomb, E. H. Soule, . Carpal, and . Syndrome,

, Minn. Med, vol.48, pp.22-33, 1965.

N. C. Neal, J. Mcmanners, and G. A. Stirling, Pathology of the flexor tendon sheath in the spontaneous carpal tunnel syndrome, J. Hand Surg. Br. Eur, vol.12, pp.229-232, 1987.

K. Stein, S. Störkel, R. P. Linke, and H. H. Goebel, Chemical heterogeneity of amyloid in the carpal tunnel syndrome, Virchows Arch. A Pathol. Anat. Histopathol, vol.412, pp.37-45, 1987.

R. A. Kyle, S. G. Eilers, R. L. Linscheid, and T. A. Gaffey, Amyloid Localized to Tenosynovium at Carpal Tunnel Release: Natural History of 124 Cases, Am. J. Clin. Pathol, vol.91, pp.393-397, 1989.

R. A. Kyle, M. A. Gertz, and R. P. Linke, Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type, Am. J. Clin. Pathol, vol.97, pp.250-253, 1992.

S. Breda, H. P. Richter, and W. Schachenmayr,

, Zentralbl. Neurochir, vol.54, pp.72-76, 1993.

S. Cordiner-lawrie, J. Diaz, P. Burge, and N. A. Athanasou, AMYLOID DEPOSITION IN TRIGGER FINGER. J. Hand Surg. Br. Eur, vol.26, pp.380-383, 2001.

Z. Gioeva, ATTR amyloid in the carpal tunnel ligament is frequently of wildtype transthyretin origin, Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis, vol.20, pp.1-6, 2013.

S. Uchiyama, Effect of synovial transthyretin amyloid deposition on preoperative symptoms and postoperative recovery of median nerve function among patients with idiopathic carpal tunnel syndrome, J. Orthop. Sci. Off. J. Jpn. Orthop. Assoc, vol.19, pp.913-919, 2014.

J. Fernández-fuertes, Ó. Rodríguez-vicente, S. Sánchez-herráez, and L. R. Ramos-pascua, Early diagnosis of systemic amyloidosis by means of a transverse carpal ligament biopsy carried out during carpal tunnel syndrome surgery, Med. Clínica Engl. Ed, vol.148, pp.211-214, 2017.

. Plast and . Chir, , vol.50, pp.329-334, 2018.

K. Scott, C. Conley, and K. Renfree, Histopathologic Evaluation of Flexor Tenosynovium in Recurrent Carpal Tunnel Syndrome, Plast. Reconstr. Surg, vol.143, pp.169-175, 2019.

I. Zegri-reiriz, Prevalence of Cardiac Amyloidosis in Patients with Carpal Tunnel Syndrome, J Cardiovasc. Transl. Res, 2019.

A. Galat, Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?, Eur. Heart J, vol.37, pp.3525-3531, 2016.

J. G. Dumesnil, P. Pibarot, and B. Carabello, Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment, Eur. Heart J, vol.31, pp.281-289, 2010.

S. Bokhari, R. Shahzad, A. Castaño, and M. S. Maurer, Nuclear imaging modalities for cardiac amyloidosis, J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol, vol.21, pp.175-184, 2014.

S. Dorbala, SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization, J. Nucl. Cardiol. Off. Publ. Am. Soc. Nucl. Cardiol, 2019.

F. Dali, Intracardiac Thrombosis and Anticoagulation Therapy in Cardiac Amyloidosis, Circulation, vol.119, pp.2490-2497, 2009.

S. Dubrey, A. Pollak, M. Skinner, and R. H. Falk, Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation, Heart, vol.74, pp.541-544, 1995.

E. A. El-am, Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis, J. Am. Coll. Cardiol, vol.73, pp.589-597, 2019.

D. Russo, L. R. Limite, L. Arcari, C. Autore, and M. B. Musumeci, Predicting the Unpredictable: How to Score the Risk of Stroke in Cardiac Amyloidosis?, J. Am. Coll. Cardiol, vol.73, pp.2910-2911, 2019.

G. J. Fitzmaurice, V. Wishart, and A. N. Graham, An unexpected mortality following cardiac surgery: a post-mortem diagnosis of cardiac amyloidosis, Gen. Thorac. Cardiovasc. Surg, vol.61, pp.417-421, 2013.

M. Raul, Cause of Complete Atrioventricular Block After Percutaneous Aortic Valve Implantation, Circulation, vol.120, pp.29-30, 2009.

J. P. Donnelly, M. Hanna, B. W. Sperry, and W. Seitz, Red-Flag Sign of Amyloidosis, Carpal Tunnel Syndrome: A Potential Early, vol.44, pp.868-876, 2019.

R. M. Witteles, Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice, JACC Heart Fail, vol.7, pp.709-716, 2019.